Last reviewed · How we verify
carboxymethylcellulose sodium based Eye Drops
Carboxymethylcellulose sodium eye drops work by forming a protective barrier on the surface of the eye to help soothe and lubricate dry eyes.
Carboxymethylcellulose sodium eye drops work by forming a protective barrier on the surface of the eye to help soothe and lubricate dry eyes. Used for Treatment of dry eye syndrome.
At a glance
| Generic name | carboxymethylcellulose sodium based Eye Drops |
|---|---|
| Also known as | Refresh Tears®, REFRESH PLUS® |
| Sponsor | Allergan |
| Drug class | Ophthalmic lubricant |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
This protective barrier helps to reduce friction between the eyelid and the eye, which can help to alleviate symptoms of dry eye syndrome. By providing a stable and consistent layer of lubrication, carboxymethylcellulose sodium eye drops can help to promote healing and reduce inflammation in the eye.
Approved indications
- Treatment of dry eye syndrome
Common side effects
- Eye irritation
Key clinical trials
- Comparative Efficacy of Lipid Based Artificial Tears vs Aqueous Based Artificial Tears in Managing EDE (NA)
- Tear Lipid Layer Thickness With Emollient Eye Drops (PHASE4)
- Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED (NA)
- Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy (PHASE4)
- Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease (PHASE3)
- A Study to Compare a New Eye Drop Formulation With Refresh Contacts® (PHASE3)
- Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease (PHASE3)
- A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- carboxymethylcellulose sodium based Eye Drops CI brief — competitive landscape report
- carboxymethylcellulose sodium based Eye Drops updates RSS · CI watch RSS
- Allergan portfolio CI